Overexpression of GD3 synthase induces apoptosis of vascular endothelial ECV304 cells through downregulation of Bcl-2
- PMID: 15196944
- DOI: 10.1016/j.febslet.2004.05.020
Overexpression of GD3 synthase induces apoptosis of vascular endothelial ECV304 cells through downregulation of Bcl-2
Abstract
The disialoganglioside GD3 plays a major role in proliferation, differentiation, and apoptosis. It has been reported that ganglioside GD3 can induce apoptosis through bcl-2 mediated mitochondrial pathway. However, the relationship between ganglioside GD3 and B-cell/CLL lymphoma 2 (Bcl-2) is not fully understood. In this study, we have demonstrated that the downregulation of Bcl-2 by overexpression of CMP-NeuAc:GM3 alpha-2,8-sialyltransferase (GD3 synthase) results in an accelerated apoptosis in vascular endothelial cells (ECV304), as evidenced by DNA fragmentation and caspase-3 activation. In addition, phosphorylation of AKT and cyclic-AMP responsive element binding protein (CREB) was reduced by GD3 synthase overexpression. Moreover, the activation of CREB as a transcriptional factor was also inhibited, as evidenced by electrophoretic mobility shift assay. Therefore, we conclude that GD3 synthase has an apoptotic effect on ECV304 cells through downregulation of Bcl-2 expression via dephosphorylation of AKT and CREB.
Similar articles
-
Melittin induces Bcl-2 and caspase-3-dependent apoptosis through downregulation of Akt phosphorylation in human leukemic U937 cells.Toxicon. 2008 Jan;51(1):112-20. doi: 10.1016/j.toxicon.2007.08.015. Epub 2007 Sep 2. Toxicon. 2008. PMID: 17936321
-
Phosphatidylinositol 3-kinase (PI-3K)/Akt but not PI-3K/p70 S6 kinase signaling mediates IGF-1-promoted lens epithelial cell survival.Invest Ophthalmol Vis Sci. 2004 Oct;45(10):3577-88. doi: 10.1167/iovs.04-0279. Invest Ophthalmol Vis Sci. 2004. PMID: 15452065
-
Key regulators in bee venom-induced apoptosis are Bcl-2 and caspase-3 in human leukemic U937 cells through downregulation of ERK and Akt.Int Immunopharmacol. 2006 Dec 5;6(12):1796-807. doi: 10.1016/j.intimp.2006.07.027. Epub 2006 Aug 22. Int Immunopharmacol. 2006. PMID: 17052670
-
Endothelial cell apoptosis: biochemical characteristics and potential implications for atherosclerosis.J Mol Cell Cardiol. 2001 Sep;33(9):1673-90. doi: 10.1006/jmcc.2001.1419. J Mol Cell Cardiol. 2001. PMID: 11549346 Review.
-
Enzyme assay of glycolipid glycosyltransferases: GD3 synthase (α2,8-sialyltransferase, ST8SIAI).2022 Jan 8 [updated 2022 Mar 22]. In: Nishihara S, Angata K, Aoki-Kinoshita KF, Hirabayashi J, editors. Glycoscience Protocols (GlycoPODv2) [Internet]. Saitama (JP): Japan Consortium for Glycobiology and Glycotechnology; 2021–. 2022 Jan 8 [updated 2022 Mar 22]. In: Nishihara S, Angata K, Aoki-Kinoshita KF, Hirabayashi J, editors. Glycoscience Protocols (GlycoPODv2) [Internet]. Saitama (JP): Japan Consortium for Glycobiology and Glycotechnology; 2021–. PMID: 37590751 Free Books & Documents. Review. No abstract available.
Cited by
-
Disialyl GD2 ganglioside suppresses ICAM-1-mediated invasiveness in human breast cancer MDA-MB231 cells.Int J Biol Sci. 2017 Feb 12;13(3):265-275. doi: 10.7150/ijbs.16903. eCollection 2017. Int J Biol Sci. 2017. PMID: 28367091 Free PMC article.
-
Exogenous and Endogeneous Disialosyl Ganglioside GD1b Induces Apoptosis of MCF-7 Human Breast Cancer Cells.Int J Mol Sci. 2016 Apr 30;17(5):652. doi: 10.3390/ijms17050652. Int J Mol Sci. 2016. PMID: 27144558 Free PMC article.
-
The good, the bad, and the unknown nature of decreased GD3 synthase expression.Front Mol Neurosci. 2024 Nov 22;17:1465013. doi: 10.3389/fnmol.2024.1465013. eCollection 2024. Front Mol Neurosci. 2024. PMID: 39649107 Free PMC article.
-
Galactosylceramide Upregulates the Expression of the BCL2 Gene and Downregulates the Expression of TNFRSF1B and TNFRSF9 Genes, Acting as an Anti-Apoptotic Molecule in Breast Cancer Cells.Cancers (Basel). 2024 Jan 17;16(2):389. doi: 10.3390/cancers16020389. Cancers (Basel). 2024. PMID: 38254878 Free PMC article.
-
Induction of GD3/α1-adrenergic receptor/transglutaminase 2-mediated erythroid differentiation in chronic myelogenous leukemic K562 cells.Oncotarget. 2017 Aug 9;8(42):72205-72219. doi: 10.18632/oncotarget.20080. eCollection 2017 Sep 22. Oncotarget. 2017. PMID: 29069780 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials